EUVIMEDEUVIMED entdecken
Crossref

Evaluation of proanthocyanidins in treating Type 2 diabetic osteoporosis via SIRT6 /Nrf2/ GPX4 pathways

Run-Xun Ma iD, Bing-Hao Lin iD, Si-Xiang Feng iD, Yi-Tian Bu iD, Zi-Hao Chen iD, Yi-Xun Huang iD, En-Li Li iD, She-Ji Weng iD, Lei Yang iD

The FASEB Journal · 2025

DOI: 10.1096/fj.202403032r ↗

Kurz gefasst

Fachartikel in der Zeitschrift The FASEB Journal, 2025. Verfasst von Run-Xun Ma und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopaedic, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China. Hauptthemen laut MEDLINE: NF-E2-Related Factor 2, Osteoporosis, Sirtuins, Diabetes Mellitus, Type 2. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 60 Literaturangaben. Gefördert von: Zhejiang Provincial Administration of Traditional Chinese Medicine, Wenzhou Science and Technology Bureau, Zhejiang Traditional Chinese Medicine Administration.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study investigates the therapeutic potential of proanthocyanidins (PAC) in addressing Type 2 diabetic osteoporosis (T2DOP) by activating the SIRT6/Nrf2/GPX4 signaling pathways. T2DOP is characterized by compromised bone structure and heightened oxidative stress, where ferroptosis plays a pivotal role. Utilizing a T2DOP mouse model and MC3T3‐E1 cells under high glucose conditions, we evaluated the impact of PAC on bone health and iron homeostasis. Our results, obtained through micro‐CT, histological staining, Western blot, and immunofluorescence analyses, revealed reductions in bone density and decreased GPX4 expression in T2DOP conditions, indicating ferroptosis and oxidative stress. However, PAC treatment improved trabecular bone structure, reduced bone marrow adipocytes, decreased oxidative stress, and enhanced expression of key osteogenic proteins. These findings highlight PAC's potential in mitigating T2DOP through the SIRT6/Nrf2/GPX4 pathways, offering promising therapeutic insights for managing diabetic osteoporosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NF-E2-Related Factor 2OsteoporosisSirtuinsDiabetes Mellitus, Type 2Phospholipid Hydroperoxide Glutathione PeroxidaseProanthocyanidinsAnimalsMiceSignal TransductionOxidative StressMaleMice, Inbred C57BL

Stichwörter der Autor:innen

SIRT6/Nrf2/Gpx4 signaling pathwaysType 2 diabetic osteoporosisferroptosisglutathione peroxidase 4proanthocyanidins

Substanzen

NF-E2-Related Factor 2SirtuinsSirt6 protein, mouseNfe2l2 protein, mousePhospholipid Hydroperoxide Glutathione PeroxidaseProanthocyanidins

Autor:innen und Institutionen

  • Department of Orthopaedic, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.
  • Key Laboratory of Orthopaedics of Zhejiang Province, Wenzhou, China

ORCID-Profile: Run-Xun Ma, Bing-Hao Lin, Si-Xiang Feng, Yi-Tian Bu, Zi-Hao Chen, Yi-Xun Huang, En-Li Li, She-Ji Weng, Lei Yang

Förderung

  • Zhejiang Provincial Administration of Traditional Chinese Medicine
  • Wenzhou Science and Technology Bureau
  • Zhejiang Traditional Chinese Medicine Administration
  • Wenzhou Municipal Science and Technology Bureau

Zitieren

APA

Ma, R. X., Lin, B. H., Feng, S. X., Bu, Y. T., Chen, Z. H., Huang, Y. X., Li, E. L., Weng, S. J., & Yang, L. (2025). Evaluation of proanthocyanidins in treating Type 2 diabetic osteoporosis via SIRT6 /Nrf2/ GPX4 pathways. The FASEB Journal. https://doi.org/10.1096/fj.202403032r

Vancouver

Ma RX, Lin BH, Feng SX, Bu YT, Chen ZH, Huang YX, et al. Evaluation of proanthocyanidins in treating Type 2 diabetic osteoporosis via SIRT6 /Nrf2/ GPX4 pathways. The FASEB Journal. 2025. doi:10.1096/fj.202403032r

BibTeX
@article{Ma2025,
  author = {Ma, Run-Xun and Lin, Bing-Hao and Feng, Si-Xiang and Bu, Yi-Tian and Chen, Zi-Hao and Huang, Yi-Xun and Li, En-Li and Weng, She-Ji and Yang, Lei},
  title = {Evaluation of proanthocyanidins in treating Type 2 diabetic osteoporosis via SIRT6 /Nrf2/ GPX4 pathways},
  journal = {The FASEB Journal},
  year = {2025},
  doi = {10.1096/fj.202403032r}
}
Kostenlos starten →